Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Cells
2022 Nov 16;1122:. doi: 10.3390/cells11223630.
Show Gene links
Show Anatomy links
Intracellular Injection of Brain Extracts from Alzheimer's Disease Patients Triggers Unregulated Ca2+ Release from Intracellular Stores That Hinders Cellular Bioenergetics.
Pensalfini A
,
Umar AR
,
Glabe C
,
Parker I
,
Ullah G
,
Demuro A
.
???displayArticle.abstract???
Strong evidence indicates that amyloid beta (Aβ) inflicts its toxicity in Alzheimer's disease (AD) by promoting uncontrolled elevation of cytosolic Ca2+ in neurons. We have previously shown that synthetic Aβ42 oligomers stimulate abnormal intracellular Ca2+ release from the endoplasmic reticulum stores, suggesting that a similar mechanism of Ca2+ toxicity may be common to the endogenous Aβs oligomers. Here, we use human postmortem brain extracts from AD-affected patients and test their ability to trigger Ca2+ fluxes when injected intracellularly into Xenopus oocytes. Immunological characterization of the samples revealed the elevated content of soluble Aβ oligomers only in samples from AD patients. Intracellular injection of brain extracts from control patients failed to trigger detectable changes in intracellular Ca2+. Conversely, brain extracts from AD patients triggered Ca2+ events consisting of local and global Ca2+ fluorescent transients. Pre-incubation with either the conformation-specific OC antiserum or caffeine completely suppressed the brain extract's ability to trigger cytosolic Ca2+ events. Computational modeling suggests that these Ca2+ fluxes may impair cells bioenergetic by affecting ATP and ROS production. These results support the hypothesis that Aβ oligomers contained in neurons of AD-affected brains may represent the toxic agents responsible for neuronal malfunctioning and death associated with the disruption of Ca2+ homeostasis.
Adeoye,
Upregulated Ca2+ Release from the Endoplasmic Reticulum Leads to Impaired Presynaptic Function in Familial Alzheimer's Disease.
2022, Pubmed
Adeoye,
Upregulated Ca2+ Release from the Endoplasmic Reticulum Leads to Impaired Presynaptic Function in Familial Alzheimer's Disease.
2022,
Pubmed
Alzheimer's Association Calcium Hypothesis Workgroup,
Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis.
2017,
Pubmed
Arispe,
Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes.
1993,
Pubmed
Barghorn,
Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.
2005,
Pubmed
Bezprozvanny,
Calcium hypothesis of neurodegeneration - An update.
2019,
Pubmed
Bezprozvanny,
Caffeine-induced inhibition of inositol(1,4,5)-trisphosphate-gated calcium channels from cerebellum.
1994,
Pubmed
Braak,
Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections.
1991,
Pubmed
Cao,
A deterministic model predicts the properties of stochastic calcium oscillations in airway smooth muscle cells.
2014,
Pubmed
Cascella,
Calcium Dyshomeostasis in Alzheimer's Disease Pathogenesis.
2021,
Pubmed
Chami,
Alterations of the Endoplasmic Reticulum (ER) Calcium Signaling Molecular Components in Alzheimer's Disease.
2020,
Pubmed
Cline,
The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.
2018,
Pubmed
Cortassa,
An integrated model of cardiac mitochondrial energy metabolism and calcium dynamics.
2003,
Pubmed
D'Andrea,
Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease.
2001,
Pubmed
Dargan,
Imaging Ca2+ signals in Xenopus oocytes.
2006,
Pubmed
,
Xenbase
Demuro,
Calcium signaling and amyloid toxicity in Alzheimer disease.
2010,
Pubmed
Demuro,
Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers.
2005,
Pubmed
Demuro,
Single-channel Ca(2+) imaging implicates Aβ1-42 amyloid pores in Alzheimer's disease pathology.
2011,
Pubmed
,
Xenbase
Demuro,
Cytotoxicity of intracellular aβ42 amyloid oligomers involves Ca2+ release from the endoplasmic reticulum by stimulated production of inositol trisphosphate.
2013,
Pubmed
,
Xenbase
Demuro,
Picomolar sensitivity to inositol trisphosphate in Xenopus oocytes.
2015,
Pubmed
,
Xenbase
Forner,
Intra- and extracellular β-amyloid overexpression via adeno-associated virus-mediated gene transfer impairs memory and synaptic plasticity in the hippocampus.
2019,
Pubmed
Foskett,
Inositol trisphosphate receptor Ca2+ release channels.
2007,
Pubmed
Gong,
Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss.
2003,
Pubmed
Gąsior-Głogowska,
Challenges in Experimental Methods.
2022,
Pubmed
Ivorra,
Inositol 1,3,4,6-tetrakisphosphate mobilizes calcium in Xenopus oocytes with high potency.
1991,
Pubmed
,
Xenbase
Jensen,
Alzheimer's disease-associated peptide Aβ42 mobilizes ER Ca(2+) via InsP3R-dependent and -independent mechanisms.
2013,
Pubmed
Kayed,
Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Aβ oligomers.
2010,
Pubmed
Kayed,
Conformation-dependent anti-amyloid oligomer antibodies.
2006,
Pubmed
Kayed,
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.
2003,
Pubmed
Kayed,
Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers.
2007,
Pubmed
Latulippe,
A mathematical model for the effects of amyloid beta on intracellular calcium.
2018,
Pubmed
Lee,
Amyloid β Ion Channels in a Membrane Comprising Brain Total Lipid Extracts.
2017,
Pubmed
Lesné,
A specific amyloid-beta protein assembly in the brain impairs memory.
2006,
Pubmed
Lin,
Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology.
2001,
Pubmed
Minicucci,
Quantifying the dose-dependent impact of intracellular amyloid beta in a mathematical model of calcium regulation in xenopus oocyte.
2021,
Pubmed
,
Xenbase
Parker,
Caffeine inhibits inositol trisphosphate-mediated liberation of intracellular calcium in Xenopus oocytes.
1991,
Pubmed
,
Xenbase
Parys,
Isolation, characterization, and localization of the inositol 1,4,5-trisphosphate receptor protein in Xenopus laevis oocytes.
1992,
Pubmed
,
Xenbase
Pelucchi,
Synaptic dysfunction in early phases of Alzheimer's Disease.
2022,
Pubmed
Pensalfini,
Intracellular amyloid and the neuronal origin of Alzheimer neuritic plaques.
2014,
Pubmed
Podlisny,
Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red.
1998,
Pubmed
Pollard,
Ion channel hypothesis for Alzheimer amyloid peptide neurotoxicity.
1995,
Pubmed
Popugaeva,
Dysregulation of Intracellular Calcium Signaling in Alzheimer's Disease.
2018,
Pubmed
Reiss,
Alzheimer Disease Clinical Trials Targeting Amyloid: Lessons Learned From Success in Mice and Failure in Humans.
2021,
Pubmed
Schrank,
Calcium-Handling Defects and Neurodegenerative Disease.
2020,
Pubmed
Schrank,
Human-Induced Neurons from Presenilin 1 Mutant Patients Model Aspects of Alzheimer's Disease Pathology.
2020,
Pubmed
Siddiqi,
Cytotoxic species in amyloid-associated diseases: Oligomers or mature fibrils.
2019,
Pubmed
Smith,
Imaging the quantal substructure of single IP3R channel activity during Ca2+ puffs in intact mammalian cells.
2009,
Pubmed
Taylor,
IP(3) receptors: the search for structure.
2004,
Pubmed
Toglia,
Data-driven modeling of mitochondrial dysfunction in Alzheimer's disease.
2018,
Pubmed
,
Xenbase
Toglia,
The gain-of-function enhancement of IP3-receptor channel gating by familial Alzheimer's disease-linked presenilin mutants increases the open probability of mitochondrial permeability transition pore.
2016,
Pubmed
Toglia,
Impaired mitochondrial function due to familial Alzheimer's disease-causing presenilins mutants via Ca(2+) disruptions.
2016,
Pubmed
Tomic,
Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction.
2009,
Pubmed
Tong,
Calcium signaling in Alzheimer's disease & therapies.
2018,
Pubmed
Ullah,
Multi-scale data-driven modeling and observation of calcium puffs.
2012,
Pubmed
Vais,
Permeant calcium ion feed-through regulation of single inositol 1,4,5-trisphosphate receptor channel gating.
2012,
Pubmed
Yamasaki-Mann,
Modulation of endoplasmic reticulum Ca2+ store filling by cyclic ADP-ribose promotes inositol trisphosphate (IP3)-evoked Ca2+ signals.
2010,
Pubmed
,
Xenbase
